Reliq Health Technologies, Inc. Announces Upcoming Shareholder Update Webinar

Rhea-AI Summary

Reliq Health Technologies Inc. (OTC:RQHTF) announced a webinar on June 1, 2021, to discuss Q3 FY2021 financial results and company updates. CEO Dr. Lisa Crossley stated the company aims for profitability by June 2021, essential for its planned NASDAQ uplisting. Reliq forecasts $11 million in revenue for the year, with gross margins of 75% and EBITDA margins of 45%. The company is expanding its Care Management team to meet increasing demand, bolstered by successful vaccine rollouts and state reopenings.

Positive

• Projected revenue of approximately $11 million for calendar year 2021.
• Gross margins expected to be 75% and EBITDA margins at 45%.
• Management anticipates reaching profitability by the end of June 2021.

Negative

• None.

HAMILTON, Ontario, May 13, 2021 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, wishes to inform shareholders that it will be hosting a webinar on June 1, 2021 at 6:00am PDT / 9:00am EDT to review the Company’s quarterly financial statements for Q3 Fiscal Year 2021 (January 1 – March 31, 2021), and provide a corporate update.

Webinar Login Information:

	Date:	Tuesday, June 1, 2021
	Time:	6:00am PDT / 9:00am EDT
	URL:	www.reliqhealth.com/webinar

“In the webinar on June 1^st, Management will discuss the Q3 FY2021 financials, provide an update on Reliq’s operations to date and review guidance for the remainder of calendar year 2021,” said Dr. Lisa Crossley, CEO at Reliq Health Technologies, Inc. “The Company remains on track to reach profitability by the end of June 2021, which is a key milestone for the business. Achieving profitability is the first step on our path to uplisting to the NASDAQ and will enable us to begin the application process. Reliq expects to generate revenues of approximately $11 Million in calendar year 2021 with gross margins of 75% and EBITDA margins of 45% by the end of this year. Thanks to a successful vaccine rollout, most US States are moving quickly to reopen and Reliq is consistently increasing the pace of onboarding and the corresponding revenue generated every month. The Company has expanded its Care Management team in the US based on existing customer demand and is well prepared to support the rapid growth expected throughout the remainder of 2021.”

For those who are not able to attend the webinar, a recording will be available on the Company’s website (www.reliqhealth.com) immediately following the session.

Reliq Health

Reliq Health Technologies is a rapidly growing global telemedicine company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB.

ON BEHALF OF THE BOARD

“Dr. Lisa Crossley”

CEO and Director

For further information please contact:

Company Contact
Investor Relations at ir@reliqhealth.com

US Investor Relations Contact
Investor Relations
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
646-829-9701
shamsian@lythampartners.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.

FAQ

What are the financial forecasts for Reliq Health Technologies in 2021?

Reliq Health Technologies expects to generate approximately $11 million in revenue with gross margins of 75% and EBITDA margins of 45% by the end of 2021.

When will Reliq Health announce its Q3 FY2021 results?

Reliq Health will host a webinar on June 1, 2021, to discuss its Q3 FY2021 financial results and provide an operational update.

What milestone is Reliq Health targeting by June 2021?

Reliq Health aims to achieve profitability by the end of June 2021, which is a key milestone for its plans to uplist to NASDAQ.

How is Reliq Health preparing for growth in 2021?

Reliq Health is expanding its Care Management team in the US to support increasing customer demand and revenue generation.